• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

3 High-Yield Small-Cap Stocks for High Returns

These smaller names have the potential to deliver exceptional total returns.
By BOB CIURA
Mar 31, 2023 | 02:16 PM EDT

While large blue-chip dividend growth stocks enable investors to sleep well at night and enjoy the benefits of attractive risk-adjusted long-term compounding, smaller cap stocks have the potential to deliver exceptional total returns as they generally enjoy much greater growth potential and often offer higher dividend yields as well.

Below, we will cover three small-cap stocks that we think offer attractive total return potential.

Bulk Up on This 'Slim Down' Name

Medifast (MED) is a weight loss and nutrition company based in Baltimore, Maryland. They operate through their health and wellness community called OPTAVIA, which offers exclusive nutritional products through nearly 60,000 independent coaches. These coaches earn commissions for marketing and selling OPTAVIA products to their clients. The OPTAVIA brand accounts for 98% of the company's revenue, which is why they focus on increasing the number of coaches promoting their brand.

Medifast has achieved a 35.6% compound annual growth rate (CAGR) in earnings per share over the past nine years. The increase in independent coaches within the business has driven this growth, with 60,900 coaches today compared to 12,500 in 2016. However, inflation and rising costs have weighed on the company's growth in the latter half of 2022.

Medifast has a large potential market, with over 42% of Americans suffering from obesity. However, due to the cyclical nature of the business and increased costs, the EPS forecast has been downgraded to 3% annually through 2028. First-quarter 2023 EPS guidance is between $1.75 and $2.40, with an estimated FY 2023 EPS of ~$9.60. The company has a solid dividend policy, with an average 34% increase over the last five years, but a more conservative approach predicts a 5% increase, targeting $8.37 per share by 2028.

Medifast's main competitive advantage is its doctor-developed program for fast, safe, and sustained weight loss, which has been backed by over 20,000 doctors since 1980. The company claims an 86% retention rate due to this program. However, the weight loss industry is highly competitive, with a low entry barrier and constantly evolving trends and products. Medifast's business model relies heavily on increasing the number of coaches, who advertise and sell the company's brands to friends and family, with a decline in coaches potentially leading to a sharp decline in revenue.

With a 6.4% dividend yield, a forecasted 3% EPS CAGR, and an expected 7.1% annualized tailwind from valuation multiple expansion, MED is poised to deliver exceptional 16.5% annualized total returns over the next half decade.

Green Mountain Dividends

Ethan Allen Interiors (ETD) is a vertically integrated interior design company that sells home furnishings online and through its network of approximately 302 design centers. The company generates 84% of its sales from its Retail segment and 16% from its Wholesale segment, which includes sales from independently owned stores.

Ethan Allen suffered during the pandemic due to the closure of its service centers but recovered quickly thanks to pent-up demand and fiscal stimulus packages. The company is positioned to continue benefiting from long-term work from home trends and follows a build-to-order business model customized to the customer's preference.

The company has enjoyed an average annualized growth rate of 12.9% in EPS over the past nine years. However, EPS is expected to fall slightly to $3.50 in 2023 as excess demand subsides. The company is expected to grow its bottom line by 2.0% per year on average beyond this year in the coming half decade.

The company has a history of increasing dividends, growing by 13.8% per year on average over the last decade and 11.0% per year on average over the last five years. The dividend is expected to grow in line with EPS, and the company has a 25-year consecutive history of paying dividends, indicating confidence in its continued payment.

Ethan Allen has had an average payout ratio of 48.2% over the past nine years, and with expected EPS growth, the company is likely to continue to have a low payout ratio in the intermediate term. The business has no debt, but it is vulnerable to economic downturns. Ethan Allen is not the cheapest retailer in its markets, but it has competitive advantages such as vertical integration, North American manufacturing operations, and made-to-order products.

With a 4.7% dividend yield, a forecasted 2% EPS CAGR, and an expected 9.2% annualized tailwind from valuation multiple expansion, ETD is poised to deliver exceptional 15.9% annualized total returns over the next half decade.

Print This: Poised for Strong Total Returns

Ennis, Inc. (EBF) is a printing and business documents company that has been able to maintain and generate shareholder value despite declining print volumes by offering additional services and add-ons. The company has also been actively acquiring other printing businesses over the past five years, with recent acquisitions including AmeriPrint and School Photo Marketing. With other players exiting the industry, Ennis is well-positioned to continue making beneficial acquisitions and further consolidate its competitive standing in the sector.

The company has had a volatile EPS track record due to challenging market conditions but has offset demand destruction through M&A. Ennis has returned capital to shareholders through a large dividend and has almost doubled its size over the past decade. The company's future earnings growth will depend largely on its ability to make future acquisitions.

Ennis has averaged a payout ratio of 70% over the past decade, and its current payout ratio of 61% should be supported by current earnings, but the company may find it challenging to maintain its dividend during a recession or sharp downturn in its industry. Ennis has a strong balance sheet, with $87 million in cash and no long-term debt, but management has indicated that it may use debt to fund an acquisition if the right deal arises.

With a 4.8% dividend yield, a forecasted 3% EPS CAGR, and an expected 3.1% annualized tailwind from valuation multiple expansion, EBF is poised to deliver strong 10.9% annualized total returns over the next half decade.

Final Thoughts

While small-cap stocks come with a bit of extra risk relative to large cap blue-chips, as our analysis of stocks such as MED, ETD, and EBF indicates, with greater risk comes greater reward potential. By prudently building a well-diversified portfolio of small-cap businesses, investors can generate outsized current income along with the potential to enjoy double-digit long-term annualized total returns without going out too far on the risk spectrum.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Ciura had no positions in any securities mentioned.

TAGS: Dividends | Fundamental Analysis | Investing | Small Cap | Value Investing | U.S. Equity

More from Investing

It's Big-Cap AI Stocks Vs. Everything Else

James "Rev Shark" DePorre
May 30, 2023 4:35 PM EDT

The biggest problem now is that the big-cap names are not acting as leaders.

Beyond Meat and Peloton: Zombie Stocks Can Turn Portfolios Into the Walking Dead

Brad Ginesin
May 30, 2023 3:30 PM EDT

Don't confuse a stock revival masquerading as a living, breathing business revival.

In Case You Missed It: Apple Just Hit a New 52-Week High

Bruce Kamich
May 30, 2023 2:45 PM EDT

Let's not ignore the strength in AAPL.

Where Can Investors Slip Into Shares of Skechers?

Bruce Kamich
May 30, 2023 2:29 PM EDT

The charts show where SKX's prices would be the perfect fit.

How Many Forward Gears Does Ferrari Stock Have?

Bruce Kamich
May 30, 2023 1:51 PM EDT

Let's check under the hood.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:48 AM EDT CHRIS VERSACE

    Latest AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • 03:25 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Don't Just Sit There and 'Hope' for Your Stocks, M...
  • 07:32 AM EDT BOB LANG

    Webinar Thursday After the Close: Option Spread Trading

    Thursday, my good friend and colleague Sam DeMarco...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login